Position in CRNX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$299,434
+$7,930 QoQ
Shares Held
8,002
-0.3% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#174
of 266 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CRNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026COMMERCE BANK holds $32,396,174 across 26 Biotechnology names. CRNX ranks #20 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
7,131 | $4,446,463 | |
| 2 | EXEL |
Exelixis, Inc.
|
78,937 | $4,294,961 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
8,033 | $3,990,231 | |
| 4 | MRNA |
Moderna, Inc.
|
55,243 | $3,868,667 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
9,461 | $2,848,043 | |
| 6 | TECH |
BIO-TECHNE Corp
|
33,609 | $2,374,475 | |
| 7 | INCY |
Incyte Corp
|
20,084 | $2,276,721 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
17,206 | $1,346,712 |
All Filings in CRNX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $299,434 | 8,002 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $291,504 | 8,026 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $373,284 | 8,019 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $315,498 | 7,575 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $229,647 | 7,985 | Shares | Defined | 2025-08-07 | |
| 2025-03-31 | $211,972 | 6,320 | Shares | Defined | 2025-05-08 | |
| 2024-12-31 | $210,911 | 4,125 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $212,320 | 4,155 | Shares | Sole | 2024-11-08 | |
| No filing history on record for this holder in this stock. | ||||||